Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
A $7 per metric ton carbon tax could reduce emissions by the same amount as the flagship climate policies of the Obama administration, a new study finds.
By
National Capital Protocol Toolkit (NCT) offers companies a structured process to identify key business risks and opportunities in their management of natural resources.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
A free, updated simulator allows users to visualize environmental impacts and better guide climate decision-making in their organizations.
By
Academics often use the En-ROADS climate solution simulator with their students, but Dr. Petra Molthan-Hill is getting the tool in front of leaders in the public and private sector.
By
The 2023 MIT Sustainability Summit in April tackled carbon markets from the perspective of consumers, small companies, and big corporations.
By
A new course on responsible negotiation at the European University Institute’s School of Transnational Governance has now left its mark on the C-ROADS World Climate Simulation—a mark that could make the activity even more useful to today’s climate negotiators.
By
Over 1,300 Sloanies and their guests returned to campus in early June to attend MIT Sloan Reunion 2023.
By
When Rubén Lozano Aguilera, MBA ’13, submitted his MIT Sloan admission application, he stated that his ultimate goal was to work on sustainability at a major corporation—he’s reached that goal in a big way.